Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan;314(1):e232650.
doi: 10.1148/radiol.232650.

CT, MRI, and FDG PET/CT in the Assessment of Lymph Node Involvement in Pediatric Hodgkin Lymphoma: An Expert Consensus Definition by an International Collaboration on Staging Evaluation and Response Criteria Harmonization for Children, Adolescent, and Young Adult Hodgkin Lymphoma (SEARCH for CAYAHL)

Affiliations
Review

CT, MRI, and FDG PET/CT in the Assessment of Lymph Node Involvement in Pediatric Hodgkin Lymphoma: An Expert Consensus Definition by an International Collaboration on Staging Evaluation and Response Criteria Harmonization for Children, Adolescent, and Young Adult Hodgkin Lymphoma (SEARCH for CAYAHL)

Dietrich Stoevesandt et al. Radiology. 2025 Jan.

Abstract

Staging of pediatric Hodgkin lymphoma is currently based on the Ann Arbor classification, incorporating the Cotswold modifications and the Lugano classification. The Cotswold modifications provide guidelines for the use of CT and MRI. The Lugano classification emphasizes the importance of CT and PET/CT in evaluating both Hodgkin lymphoma and non-Hodgkin lymphoma but focuses on adult patients. This article presents consensus guidelines that extend the traditional classifications used for adult Hodgkin lymphoma staging and provide rigorous definitions of lymph node groups based on MRI, CT, and fluorodeoxyglucose PET/CT findings. This allows consistent terminology and definitions, using metabolic and morphologic imaging to identify affected lymph nodes or extranodal regions and organs. The pattern of involvement, together with other individual risk factors, determines treatment strategy. In case of inadequate response to chemotherapy, radiation therapy is often required. Standardization of staging definitions for pediatric Hodgkin lymphoma is necessary for comparing treatment outcomes between North American and European clinical trials and a prerequisite for clear communication during tumor boards and central review. This comprehensive imaging atlas is intended to provide regional criteria for nodal involvement and to serve as a standardized guide for the anatomic assignment of lymph node involvement in pediatric Hodgkin lymphoma.

PubMed Disclaimer

Conflict of interest statement

Disclosures of conflicts of interest: D.S. No relevant relationships. J.S. Support from the St Jude Children’s Research Hospital for attending the Fifth International Symposium on Childhood, Adolescent, and Young Adult Hodgkin Lymphoma (ISCAYAHL). J.M.B. No relevant relationships. L.K. No relevant relationships. K.M.M. Member of Organizing Committee for the 2024 international meeting of ISCAYAHL (International Symposium on Childhood, Adolescent, and Young Adult Hodgkin Lymphoma). J.E.F. No relevant relationships. T.W.G. No relevant relationships. C.M.K. Institution received a research grant from Merck Pharma, EuroNet PHL scientific secretary (unpaid). S.Y.C. Member of Radiology editorial board. D.K. The EuroNet-PHL-C2 trial was supported by Deutsche Krebshilfe; until October 2023 has been the chairperson of the GPOH-HD Study Group elected by the German Childhood Cancer Society. R.K. No relevant relationships. K.M.K. Institution received payments for author’s effort related to this research through the Children's Oncology Group‘s grant from NIH/NCI; institution receives payment related to Hodgkin lymphoma research through the CDRMP Research Program and through the Children's Oncology Group and supported by Merck; author received honoraria for lectures on Hodgkin lymphoma support through continuing medical education companies; author received support for attending the American Society of Pediatric Hematology/Oncology annual meeting in 2023 for presentation on pediatric Hodgkin lymphoma; chair of the Pediatric Hodgkin lymphoma NCCN Guidelines Panel (unpaid); scientific advisory board member for Seagen (unpaid, term ended in 2023); member of the Scientific Advisory Board of the Lymphoma Research Foundation (unpaid). T.P. No relevant relationships. D.V. Vice president of German Society of Radiation Oncology. B.S.H. Received payment for educational CME development on radiation use on AHOD 1331; Children's Oncology Group funded travel to semi-annual meetings as the lead radiation oncologist on the pediatric Hodgkin lymphoma subcommittee; scientific advisory board for a Children’s Oncology Group study 1822 with Merck, contracted between Mayo Clinic and COG; NRG Hematologic Malignancy Working Group co-chair (unpaid). K.D. No relevant relationships. S.D.V. Received payment for expert testimony (2022 Pulaski County Court, No. 60CV-20-2053, legal fees from Hugh Crisp, LLC, and Anderson, Murphy, Hopkins, LLC; travel support for attending and presenting at the Eighth International Symposium on Pediatric Solid Tumors: Neuroblastoma in Tübingen, Germany.

Figures

None
Graphical abstract
Consort diagram of consensus process for establishing lymph node or nodal
region definitions in pediatric Hodgkin lymphoma. SEARCH for CAYAHL (Staging
Evaluation and Response Criteria Harmonization for Childhood, Adolescent and
Young Adult Hodgkin Lymphoma) is an international consortium formed in 2011,
focused on harmonizing staging and response criteria for pediatric Hodgkin
lymphoma, with representatives from the EuroNet Pediatric Hodgkin Lymphoma
committee, the Children’s Oncology Group Hodgkin Lymphoma committee, and
the St Jude Consortium Pediatric Hodgkin Lymphoma Committee.
Figure 1:
Consort diagram of consensus process for establishing lymph node or nodal region definitions in pediatric Hodgkin lymphoma. SEARCH for CAYAHL (Staging Evaluation and Response Criteria Harmonization for Childhood, Adolescent and Young Adult Hodgkin Lymphoma) is an international consortium formed in 2011, focused on harmonizing staging and response criteria for pediatric Hodgkin lymphoma, with representatives from the EuroNet Pediatric Hodgkin Lymphoma committee, the Children’s Oncology Group Hodgkin Lymphoma committee, and the St Jude Consortium Pediatric Hodgkin Lymphoma Committee.
Overview of independent lymph node regions used to determine the sites of
involvement in pediatric Hodgkin lymphoma. Adapted from the original figure by
Kaplan and Rosenberg (28) and reproduced, with permission, from reference
35.
Figure 2:
Overview of independent lymph node regions used to determine the sites of involvement in pediatric Hodgkin lymphoma. Adapted from the original figure by Kaplan and Rosenberg (28) and reproduced, with permission, from references .
Upper cervical lymph nodes (left and right). The upper cervical lymph
node regions are shown in coronal and axial planes on a contrast-enhanced CT
scan in a 17-year-old male patient in complete remission. The upper cervical
(turquoise), lower cervical (yellow), and supraclavicular (blue) lymph node
regions are shown together with their corresponding borders. The upper
cervical lymph nodes correspond to level IIa and IIb nodal groups proposed
by Grégoire et al (18).
Figure 3:
Upper cervical lymph nodes (left and right). The upper cervical lymph node regions are shown in coronal and axial planes on a contrast-enhanced CT scan in a 17-year-old male patient in complete remission. The upper cervical (turquoise), lower cervical (yellow), and supraclavicular (blue) lymph node regions are shown together with their corresponding borders. The upper cervical lymph nodes correspond to level IIa and IIb nodal groups proposed by Grégoire et al (18).
Lower cervical lymph nodes (left and right). The lower cervical lymph
node region (yellow) is shown on a contrast-enhanced axial CT scan in a
17-year-old male patient. These lymph nodes correspond to level III and VIa
nodal groups proposed by Grégoire et al (18).
Figure 4:
Lower cervical lymph nodes (left and right). The lower cervical lymph node region (yellow) is shown on a contrast-enhanced axial CT scan in a 17-year-old male patient. These lymph nodes correspond to level III and VIa nodal groups proposed by Grégoire et al (18).
Supraclavicular lymph nodes (left and right). The supraclavicular
(blue), infraclavicular (purple), and axillary (red) lymph node regions are
shown on a contrast-enhanced axial CT scan in a 17-year-old male patient.
These lymph nodes correspond to level IV, Vb, Vc, and VI nodal groups
proposed by Grégoire et al (18).
Figure 5:
Supraclavicular lymph nodes (left and right). The supraclavicular (blue), infraclavicular (purple), and axillary (red) lymph node regions are shown on a contrast-enhanced axial CT scan in a 17-year-old male patient. These lymph nodes correspond to level IV, Vb, Vc, and VI nodal groups proposed by Grégoire et al (18).
Infraclavicular and perctoral lymph nodes (left and right). The
infraclavicular region (purple) is separated from the axillary lymph node
region (red) by a dividing line (orange) shown on a contrast-enhanced axial
CT scan in a 17-year-old male patient. The upper mediastinal lymph node
region (green) is also shown. These lymph nodes correspond to level II, III,
and interpectoral nodal groups proposed by Lengelé et al
(20).
Figure 6:
Infraclavicular and perctoral lymph nodes (left and right). The infraclavicular region (purple) is separated from the axillary lymph node region (red) by a dividing line (orange) shown on a contrast-enhanced axial CT scan in a 17-year-old male patient. The upper mediastinal lymph node region (green) is also shown. These lymph nodes correspond to level II, III, and interpectoral nodal groups proposed by Lengelé et al (20).
Axillary lymph nodes (left and right). The axillary region (red) is
separated from the infraclavicular lymph node region (purple) by a dividing
line (orange) shown on a contrast-enhanced axial CT scan in a 17-year-old
male patient. The upper mediastinal (green) and the internal mammary
(turquoise) lymph node regions are also shown. These lymph nodes correspond
to level 1 nodal group proposed by Lengelé et al (20).
Figure 7:
Axillary lymph nodes (left and right). The axillary region (red) is separated from the infraclavicular lymph node region (purple) by a dividing line (orange) shown on a contrast-enhanced axial CT scan in a 17-year-old male patient. The upper mediastinal (green) and the internal mammary (turquoise) lymph node regions are also shown. These lymph nodes correspond to level 1 nodal group proposed by Lengelé et al (20).
Hilar lymph nodes of the right lung. The right hilar region (blue)
with medial borders (orange line to the right of midline) is shown on a
contrast-enhanced axial CT scan in a 17-year-old male patient. Other regions
shown are left hilar (blue), upper mediastinal (green), lower mediastinal
(yellow), axillary (red), internal mammary (turquoise), and infraclavicular
and pectoral (purple) lymph node regions. These lymph nodes correspond to
the hilar nodal stations 10–11, subdivided into right and left hilar
nodes, as defined by Chapet et al (17).
Figure 8:
Hilar lymph nodes of the right lung. The right hilar region (blue) with medial borders (orange line to the right of midline) is shown on a contrast-enhanced axial CT scan in a 17-year-old male patient. Other regions shown are left hilar (blue), upper mediastinal (green), lower mediastinal (yellow), axillary (red), internal mammary (turquoise), and infraclavicular and pectoral (purple) lymph node regions. These lymph nodes correspond to the hilar nodal stations 10–11, subdivided into right and left hilar nodes, as defined by Chapet et al (17).
Hilar lymph nodes of the left lung. The left hilar region (blue) with
medial borders (orange line to the left of midline) is shown on a
contrast-enhanced axial CT scan in a 17-year-old male patient. Other regions
shown are right hilar (blue), upper mediastinal (green), lower mediastinal
(yellow), axillary (red), internal mammary (turquoise), and infraclavicular
and pectoral (purple) lymph node regions. These lymph nodes correspond to
the hilar nodal stations 10–11, subdivided into right and left hilar
nodes, as defined by Chapet et al (17).
Figure 9:
Hilar lymph nodes of the left lung. The left hilar region (blue) with medial borders (orange line to the left of midline) is shown on a contrast-enhanced axial CT scan in a 17-year-old male patient. Other regions shown are right hilar (blue), upper mediastinal (green), lower mediastinal (yellow), axillary (red), internal mammary (turquoise), and infraclavicular and pectoral (purple) lymph node regions. These lymph nodes correspond to the hilar nodal stations 10–11, subdivided into right and left hilar nodes, as defined by Chapet et al (17).
Upper mediastinal lymph nodes. The upper mediastinal lymph node region
(green) is shown on a contrast-enhanced axial CT scan in a 17-year-old male
patient. Other regions shown are left and right hilar (blue), lower
mediastinal (yellow), axillary (red), and internal mammary (turquoise) lymph
node regions. These lymph nodes correspond to lymph node stations 1, 2, 3,
4, 5, and 6 as proposed by Chapet et al (17).
Figure 10:
Upper mediastinal lymph nodes. The upper mediastinal lymph node region (green) is shown on a contrast-enhanced axial CT scan in a 17-year-old male patient. Other regions shown are left and right hilar (blue), lower mediastinal (yellow), axillary (red), and internal mammary (turquoise) lymph node regions. These lymph nodes correspond to lymph node stations 1, 2, 3, 4, 5, and 6 as proposed by Chapet et al (17).
Internal mammary lymph nodes (left and right). The internal mammary
lymph node region (turquoise) is shown on a contrast-enhanced axial CT scan
in a 17-year-old male patient. Other regions shown are left and right hilar
(blue), lower mediastinal (yellow), axillary (red), and upper mediastinal
(green) lymph node regions. These lymph node stations are based on the
anatomic boundaries proposed by Verhoeven et al (39) and lie within the
connective tissue surrounding the left or right internal thoracic
artery.
Figure 11:
Internal mammary lymph nodes (left and right). The internal mammary lymph node region (turquoise) is shown on a contrast-enhanced axial CT scan in a 17-year-old male patient. Other regions shown are left and right hilar (blue), lower mediastinal (yellow), axillary (red), and upper mediastinal (green) lymph node regions. These lymph node stations are based on the anatomic boundaries proposed by Verhoeven et al (39) and lie within the connective tissue surrounding the left or right internal thoracic artery.
Lower mediastinal lymph nodes. The lower mediastinal lymph node region
(yellow) is shown on a contrast-enhanced axial CT scan in a 17-year-old male
patient. Other regions shown are left and right hilum (blue) with medial
borders (orange lines), axillary (red), internal mammary (turquoise), and
upper mediastinal (green) lymph node regions. These lymph nodes correspond
to lymph node stations 7, 8, and 9 as proposed by Chapet et al
(17).
Figure 12:
Lower mediastinal lymph nodes. The lower mediastinal lymph node region (yellow) is shown on a contrast-enhanced axial CT scan in a 17-year-old male patient. Other regions shown are left and right hilum (blue) with medial borders (orange lines), axillary (red), internal mammary (turquoise), and upper mediastinal (green) lymph node regions. These lymph nodes correspond to lymph node stations 7, 8, and 9 as proposed by Chapet et al (17).
Retrocrural and paravertebral lymph nodes The retrocrural and
paravertebral lymph node region (yellow) is a subregion of the lower
mediastinal region shown on a contrast-enhanced axial CT scan in a
17-year-old male patient. Other regions shown are splenic hilar (brown),
mesenteric (green), upper para-aortic (blue), ventral supradiaphragmatic
recess (purple), and porta hepatis (red) lymph node regions. This lymph node
region corresponds to the inferior aspect of lymph node station 9 proposed
by Chapet et al (17) and is a subregion of the lower mediastinal region
defined in Figure 12.
Figure 13:
Retrocrural and paravertebral lymph nodes The retrocrural and paravertebral lymph node region (yellow) is a subregion of the lower mediastinal region shown on a contrast-enhanced axial CT scan in a 17-year-old male patient. Other regions shown are splenic hilar (brown), mesenteric (green), upper para-aortic (blue), ventral supradiaphragmatic recess (purple), and porta hepatis (red) lymph node regions. This lymph node region corresponds to the inferior aspect of lymph node station 9 proposed by Chapet et al (17) and is a subregion of the lower mediastinal region defined in Figure 12.
Ventral supradiaphragmatic recess (left and right). The ventral
supradiaphragmatic recess (purple) is shown on a contrast-enhanced axial CT
scan in a 17-year-old male patient. Other regions shown are splenic hilar
(brown), mesenteric (green), upper para-aortic (blue), and retrocrural and
paravertebral (yellow) lymph node regions. The ventral supradiaphragmatic
recess group is the continuation of the internal mammary group from the
fourth rib downwards to the diaphragm. Lymph nodes that are distinct from a
mediastinal lymph node mass are sometimes located here.
Figure 14:
Ventral supradiaphragmatic recess (left and right). The ventral supradiaphragmatic recess (purple) is shown on a contrast-enhanced axial CT scan in a 17-year-old male patient. Other regions shown are splenic hilar (brown), mesenteric (green), upper para-aortic (blue), and retrocrural and paravertebral (yellow) lymph node regions. The ventral supradiaphragmatic recess group is the continuation of the internal mammary group from the fourth rib downwards to the diaphragm. Lymph nodes that are distinct from a mediastinal lymph node mass are sometimes located here.
Splenic hilar lymph nodes. The splenic hilar lymph node region (brown)
is shown on a contrast-enhanced axial CT scan in a 17-year-old male patient.
Other regions shown are ventral supradiaphragmatic recess (purple),
mesenteric (green), porta hepatis (red), upper para-aortic (blue), and
retrocrural and paravertebral (yellow) lymph node regions.
Figure 15:
Splenic hilar lymph nodes. The splenic hilar lymph node region (brown) is shown on a contrast-enhanced axial CT scan in a 17-year-old male patient. Other regions shown are ventral supradiaphragmatic recess (purple), mesenteric (green), porta hepatis (red), upper para-aortic (blue), and retrocrural and paravertebral (yellow) lymph node regions.
Porta hepatis lymph nodes. The porta hepatis lymph node region (red)
is shown on a contrast-enhanced axial CT scan in a 17-year-old male patient.
Other regions shown are mesenteric (green), splenic hilar (brown), and upper
para-aortic (blue) lymph node regions. This region corresponds to the course
of the hepatic artery and roughly corresponds to the level 18 lymph node
group proposed by Korst et al (42).
Figure 16:
Porta hepatis lymph nodes. The porta hepatis lymph node region (red) is shown on a contrast-enhanced axial CT scan in a 17-year-old male patient. Other regions shown are mesenteric (green), splenic hilar (brown), and upper para-aortic (blue) lymph node regions. This region corresponds to the course of the hepatic artery and roughly corresponds to the level 18 lymph node group proposed by Korst et al (42).
Mesenteric lymph nodes. The mesenteric lymph node region (green) is
shown on a contrast-enhanced axial CT scan in a 17-year-old male patient.
The upper para-aortic (blue) lymph node region is also shown. This region
corresponds to the superior, central, inferior mesenteric, and ileocolic
lymph nodes described by Lengelé et al (20).
Figure 17:
Mesenteric lymph nodes. The mesenteric lymph node region (green) is shown on a contrast-enhanced axial CT scan in a 17-year-old male patient. The upper para-aortic (blue) lymph node region is also shown. This region corresponds to the superior, central, inferior mesenteric, and ileocolic lymph nodes described by Lengelé et al (20).
Upper para-aortic lymph nodes. The upper para-aortic retroperitoneal
lymph node region (blue) is shown on a contrast-enhanced axial CT scan in a
17-year-old male patient. The mesenteric (green) lymph node region is also
shown. This region corresponds to lymph nodes node stations I and II
proposed by Lengelé et al (20).
Figure 18:
Upper para-aortic lymph nodes. The upper para-aortic retroperitoneal lymph node region (blue) is shown on a contrast-enhanced axial CT scan in a 17-year-old male patient. The mesenteric (green) lymph node region is also shown. This region corresponds to lymph nodes node stations I and II proposed by Lengelé et al (20).
Lower para-aortic lymph nodes. The lower para-aortic retroperitoneal
lymph node region (red) is shown on a contrast-enhanced axial CT scan in a
17-year-old male patient. The mesenteric (green) lymph node region is also
shown. This region corresponds to lymph node level III proposed by
Lengelé et al (20).
Figure 19:
Lower para-aortic lymph nodes. The lower para-aortic retroperitoneal lymph node region (red) is shown on a contrast-enhanced axial CT scan in a 17-year-old male patient. The mesenteric (green) lymph node region is also shown. This region corresponds to lymph node level III proposed by Lengelé et al (20).
Iliac chain lymph nodes (left and right). The iliac chain lymph node
region (yellow) is shown on a contrast-enhanced axial CT scan in a
17-year-old male patient. The mesenteric (green) lymph node region is also
shown. This region corresponds to lymph node levels I, II, III, V, and VII
proposed by Lengelé et al (19).
Figure 20:
Iliac chain lymph nodes (left and right). The iliac chain lymph node region (yellow) is shown on a contrast-enhanced axial CT scan in a 17-year-old male patient. The mesenteric (green) lymph node region is also shown. This region corresponds to lymph node levels I, II, III, V, and VII proposed by Lengelé et al (19).
Inguinal lymph nodes (left and right). The inguinal lymph node region
(purple) is shown on a contrast-enhanced axial CT scan in a 17-year-old male
patient. These lymph node regions correspond to the regions proposed by
Lengelé et al (19).
Figure 21:
Inguinal lymph nodes (left and right). The inguinal lymph node region (purple) is shown on a contrast-enhanced axial CT scan in a 17-year-old male patient. These lymph node regions correspond to the regions proposed by Lengelé et al (19).
Images in a 16-year-old male patient. (A) Axial contrast-enhanced CT
scan with arms elevated, with lymph node in the infraclavicular region. (B)
Axial noncontrast T1-weighted MRI scan with arms alongside the torso, with
lymph node in the supraclavicular region. Depending on the arm position, the
marked lymph node (arrowhead) may be assigned to different lymph node
regions.
Figure 22:
Images in a 16-year-old male patient. (A) Axial contrast-enhanced CT scan with arms elevated, with lymph node in the infraclavicular region. (B) Axial noncontrast T1-weighted MRI scan with arms alongside the torso, with lymph node in the supraclavicular region. Depending on the arm position, the marked lymph node (arrowhead) may be assigned to different lymph node regions.
Axial contrast-enhanced (A) and noncontrast (B) CT scans in a
9-year-old female patient obtained at (A) deep inspiration (end inspiration)
and at (B) resting inspiration (quiet breathing). With resting inspiration
(B), the mediastinal lymph node (orange arrowhead) is located above the
upper sternal border and is therefore assigned to the supraclavicular
region, whereas the same lesion (orange arrowhead) at deep inspiration (A)
does not cross this border. An additional lymph node (turquoise arrowhead)
is also reaching into the supraclavicular region at resting inspiration (B).
This should be taken into consideration for radiation planning
purposes.
Figure 23:
Axial contrast-enhanced (A) and noncontrast (B) CT scans in a 9-year-old female patient obtained at (A) deep inspiration (end inspiration) and at (B) resting inspiration (quiet breathing). With resting inspiration (B), the mediastinal lymph node (orange arrowhead) is located above the upper sternal border and is therefore assigned to the supraclavicular region, whereas the same lesion (orange arrowhead) at deep inspiration (A) does not cross this border. An additional lymph node (turquoise arrowhead) is also reaching into the supraclavicular region at resting inspiration (B). This should be taken into consideration for radiation planning purposes.
Axial contrast-enhanced (A) and noncontrast (B) CT scans in a
12-year-old female patient obtained at (A) deep inspiration (end
inspiration) and at (B) resting inspiration (quiet breathing). While the
right internal mammary lymph nodes (arrowhead) do not appear to be affected
by inspiration (A), the mediastinal tumor mass lies broad-based against the
ventral thoracic wall during resting inspiration (quiet breathing)
(B).
Figure 24:
Axial contrast-enhanced (A) and noncontrast (B) CT scans in a 12-year-old female patient obtained at (A) deep inspiration (end inspiration) and at (B) resting inspiration (quiet breathing). While the right internal mammary lymph nodes (arrowhead) do not appear to be affected by inspiration (A), the mediastinal tumor mass lies broad-based against the ventral thoracic wall during resting inspiration (quiet breathing) (B).
Axial T2-weighted MRI (A) and axial fused fluorodeoxyglucose (FDG)
PET/CT (B) images demonstrate the anatomic location of retrocrural lymph
adenopathy (arrowhead) in a 15-year-old male patient. Enlarged retrocrural
lymph nodes in Hodgkin lymphoma are typically FDG-avid and should be
assigned to the retrocrural and paravertebral region (see Fig 13). This is
often best demonstrated and confirmed on sagittal and coronal reformatted
images.
Figure 25:
Axial T2-weighted MRI (A) and axial fused fluorodeoxyglucose (FDG) PET/CT (B) images demonstrate the anatomic location of retrocrural lymph adenopathy (arrowhead) in a 15-year-old male patient. Enlarged retrocrural lymph nodes in Hodgkin lymphoma are typically FDG-avid and should be assigned to the retrocrural and paravertebral region (see Fig 13). This is often best demonstrated and confirmed on sagittal and coronal reformatted images.

References

    1. Hodgkin . On some Morbid Appearances of the Absorbent Glands and Spleen . Med Chir Trans 1832. ; 17 : 68 – 114 . - PMC - PubMed
    1. Schellong G , Brämswig J , Ludwig R , et al . Combined treatment strategy in over 200 children with Hodgkin's disease: graduated chemotherapy, involved field irradiation with low dosage and selective splenectomy. A report of the cooperative therapy study DAL-HD-82 [in German] . Klin Padiatr 1986. ; 198 ( 3 ): 137 – 146 . - PubMed
    1. Weiner MA , Leventhal B , Brecher ML , et al . Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin’s disease in pediatric patients: a Pediatric Oncology Group study . J Clin Oncol 1997. ; 15 ( 8 ): 2769 – 2779 . - PubMed
    1. Schellong G , Pötter R , Brämswig J , et al . High cure rates and reduced long-term toxicity in pediatric Hodgkin’s disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin’s Disease Study Group . J Clin Oncol 1999. ; 17 ( 12 ): 3736 – 3744 . - PubMed
    1. Donaldson SS , Hudson MM , Lamborn KR , et al . VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin’s disease: results of a prospective clinical trial . J Clin Oncol 2002. ; 20 ( 14 ): 3081 – 3087 . - PubMed

Substances